Sinopharm Group Co. Ltd.'s (HKG:1099) Low P/E No Reason For Excitement
Feb 16
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Healthcare Services Industry Analysis
UpdatedMar 06, 2026
DataAggregated Company Financials
Companies59
- 7D-4.0%
- 3M-8.8%
- 1Y-25.1%
- YTD-1.3%
Over the last 7 days, the Healthcare Services industry has dropped 6.6%, driven by Sinopharm Group declining 2.9%. On the other hand 160 Health International is actually up 17%. However, the industry is down 24% over the past year. Earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Hong Kong Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 06 Mar 2026 | HK$153.2b | HK$766.8b | HK$9.4b | 10.7x | 16.4x | 0.2x |
| Sun, 01 Feb 2026 | HK$157.9b | HK$761.3b | HK$9.3b | 11.7x | 17.1x | 0.2x |
| Tue, 30 Dec 2025 | HK$154.7b | HK$751.9b | HK$9.1b | 12.1x | 16.9x | 0.2x |
| Thu, 27 Nov 2025 | HK$170.8b | HK$741.5b | HK$9.0b | 12.9x | 19.1x | 0.2x |
| Sat, 25 Oct 2025 | HK$180.9b | HK$746.8b | HK$8.4b | 13.3x | 21.5x | 0.2x |
| Mon, 22 Sep 2025 | HK$231.2b | HK$823.1b | HK$11.4b | 13.5x | 20.3x | 0.3x |
| Wed, 20 Aug 2025 | HK$238.7b | HK$822.9b | HK$13.0b | 13.4x | 18.3x | 0.3x |
| Fri, 18 Jul 2025 | HK$220.5b | HK$826.4b | HK$13.0b | 13.9x | 16.9x | 0.3x |
| Sun, 15 Jun 2025 | HK$239.4b | HK$810.0b | HK$10.8b | 13x | 22.2x | 0.3x |
| Tue, 13 May 2025 | HK$213.8b | HK$801.4b | HK$10.5b | 11.7x | 20.4x | 0.3x |
| Thu, 10 Apr 2025 | HK$205.5b | HK$789.5b | HK$10.3b | 11.7x | 19.9x | 0.3x |
| Sat, 08 Mar 2025 | HK$204.6b | HK$811.0b | HK$14.6b | 12.8x | 14x | 0.3x |
| Mon, 03 Feb 2025 | HK$199.4b | HK$811.7b | HK$14.6b | 12.6x | 13.6x | 0.2x |
| Wed, 01 Jan 2025 | HK$225.5b | HK$803.4b | HK$14.5b | 12.2x | 15.6x | 0.3x |
| Fri, 29 Nov 2024 | HK$220.0b | HK$810.9b | HK$14.6b | 12.6x | 15.1x | 0.3x |
| Sun, 27 Oct 2024 | HK$220.5b | HK$824.2b | HK$14.8b | 13.6x | 14.9x | 0.3x |
| Tue, 24 Sep 2024 | HK$197.2b | HK$842.2b | HK$15.7b | 13.5x | 12.6x | 0.2x |
| Thu, 22 Aug 2024 | HK$221.5b | HK$832.6b | HK$12.7b | 10.5x | 17.4x | 0.3x |
| Sat, 20 Jul 2024 | HK$237.7b | HK$818.3b | HK$12.5b | 11x | 19x | 0.3x |
| Mon, 17 Jun 2024 | HK$261.7b | HK$821.5b | HK$12.6b | 12.4x | 20.8x | 0.3x |
| Wed, 15 May 2024 | HK$268.5b | HK$822.9b | HK$12.5b | 12.6x | 21.4x | 0.3x |
| Fri, 12 Apr 2024 | HK$226.6b | HK$821.6b | HK$12.7b | 11.8x | 17.8x | 0.3x |
| Sun, 10 Mar 2024 | HK$239.9b | HK$815.4b | HK$11.8b | 12.8x | 20.4x | 0.3x |
| Tue, 06 Feb 2024 | HK$221.7b | HK$823.8b | HK$12.2b | 13.9x | 18.2x | 0.3x |
| Thu, 04 Jan 2024 | HK$242.2b | HK$818.7b | HK$12.4b | 15.3x | 19.5x | 0.3x |
| Sat, 02 Dec 2023 | HK$256.5b | HK$820.0b | HK$12.4b | 15.4x | 20.7x | 0.3x |
| Mon, 30 Oct 2023 | HK$268.9b | HK$801.0b | HK$12.3b | 13.3x | 21.9x | 0.3x |
| Wed, 27 Sep 2023 | HK$285.9b | HK$802.6b | HK$12.7b | 13.8x | 22.6x | 0.4x |
| Fri, 25 Aug 2023 | HK$279.5b | HK$783.2b | HK$10.1b | 14.8x | 27.8x | 0.4x |
| Sun, 23 Jul 2023 | HK$330.2b | HK$806.0b | -HK$109,011,588.00 | 11.6x | -3029.3x | 0.4x |
| Tue, 20 Jun 2023 | HK$310.6b | HK$770.0b | HK$613.4m | 10.9x | 506.4x | 0.4x |
| Thu, 18 May 2023 | HK$327.9b | HK$788.1b | HK$1.0b | 11.8x | 316x | 0.4x |
| Sat, 15 Apr 2023 | HK$342.9b | HK$803.6b | HK$2.0b | 10.6x | 174.2x | 0.4x |
| Mon, 13 Mar 2023 | HK$314.9b | HK$782.1b | HK$3.5b | 15.8x | 89.9x | 0.4x |
Price to Earnings Ratio
89.9x
Current Industry PE
- Investors are pessimistic on the Hong Kong Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 16.4x which is higher than its 3-year average PE of -40.8x.
- The industry is trading close to its 3-year average PS ratio of 0.30x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 39% per year over the last three years, while revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | -2.36% | |
| Healthcare | -5.76% | |
| Healthcare Services | -4.01% | |
| Managed Healthcare | 0% | 0 |
| Healthcare Distributors | -3.54% | |
| Healthcare Services | -4.05% | |
| Healthcare Facilities | -5.13% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 40.7%, which is higher than its past year's earnings growth of 6.9% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, which is trading below its 3-year average of 12.3x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 41% over the next 5 years.
- This is better than its past earnings growth rate of 6.9% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 12% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2656 160 Health International | HK$70.15 | 4.1% +HK$925.2m | n/a | PS32.7x | |
| 2609 Bayzed Health Group | HK$3.42 | 12.9% +HK$514.2m | n/a | PS3.3x | |
| 2522 Jiangxi Rimag Group | HK$6.15 | 5.5% +HK$126.5m | -85.4% | PS2.6x | |
| 1345 Shanghai Pioneer Holding | HK$2.35 | 4.4% +HK$115.9m | 4.0% | PE23.1x | |
| 2677 Distinct Healthcare Holdings | HK$60.10 | 1.9% +HK$70.8m | n/a | PE40.8x |